Olivia Ghaw, MD, completed her fellowship training at Mount Sinai Hospital and now joins the faculty in the Division of Rheumatology at Mount Sinai School of Medicine in New York.
Dr. Ghaw received her BA from Wellesley College and her medical degree from NYU Langone Medical Center. She completed her internal medicine residency at Mount Sinai Hospital. During these times, she has participated in numerous medical humanitarian missions to underserved locations such as Mongolia, Honduras, and Western China.
Her clinical interests include connective tissue diseases, systemic lupus erythematosus, rheumatoid arthritis, vasculitis, crystal deposition diseases, spondyloarthropathies, osteoarthritis and osteoporosis.
Rheumatology
American Board of Internal Medicine
BA, WELLESLEY COLLEGE
MD, NEW YORK UNIVERSITY SCHOOL OF MEDICINE
MD, New York University School of Medicine
, MOUNT SINAI MEDICAL CENTER
, MOUNT SINAI MEDICAL CENTER
Residency, Internal Medicine
Mount Sinai Hospital
Fellowship, Rheumatology
Mount Sinai Hospital
English
Phase 2 Study of Uricase-PEG 20 in Humans with Hyperuricemia and Gout
· Preceptors: Peter D. Gorevic, M.D., Chief, Rheumatology Division
May 2005-Present
: Safety and Efficacy of Tocilizumab versus Placebo in Combination with Disease Modifying Anti-Rheumatic Drugs in Patients with Moderate to Severe Active Rheumatoid Arthritis
· Preceptors: Peter D. Gorevic, M.D., Chief, Rheumatology Division
August 2008- Present
Evaluation of Tuberculosis screening strategies in patients with Rheumatoid Arthritis using cutaneous antigen testing and whole blood Quantiferon®-TB assay
· Preceptors: Clifton O. Bingham III, M.D., and Jeffrey Greenberg, M.D.
· Site: Seligman Center for Advanced Therapeutics, NYU Hospital for Joint Diseases.
2003-2004
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Ghaw did not report having any of the following types of financial relationships with industry during 2015 and/or 2016: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website.
Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.